Hexcel Corp. (NYSE: HXL) was started with a Buy rating and a $52 price target (versus a $45.12 close) at Seaport Global.
Illumina Inc. (NASDAQ: ILMN) was downgraded to Neutral from Buy at Guggenheim.
Kinder Morgan Inc. (NYSE: KMI) was downgraded to Sell from Neutral and its price target was lowered to $15 from $16 (versus a $15.19 close) at Goldman Sachs. Kinder Morgan had a $17.85 prior consensus target price.
Nikola Corp. (NASDAQ: NKLA) was started with a Sector Perform rating and a $46 price target at RBC Capital Markets. Shares fell by over 14% to $48.92 on Monday and were down over 4% at $46.75 ahead of Tuesday’s opening bell.
Kura Oncology Inc. (NASDAQ: KURA) was started as Outperform with a $27 price target at Credit Suisse. Shares closed at $16.72, with a $24.38 consensus target price, ahead of the call.
3M Co. (NYSE: MMM) was reiterated as Underweight and its price target was cut to $156 from $159 (versus a $158.10 close) at Barclays.
Nautilus Inc. (NYSE: NLS) was reiterated as Buy and its price target was raised to $12 (versus a $10.24 close) at SunTrust Robinson Humphrey.
Nvidia Corp. (NASDAQ: NVDA) was reiterated as Buy and its price objective was raised to $460 from $420 at BofA Securities. Shares closed at $393.57 ahead of this call and had a $388.20 consensus target price. This is above the prior street-high target price of $450.
Sangamo Therapeutics Inc. (NASDAQ: SGMO) was started with a Buy rating and a $22 price target at SunTrust Robinson Humphrey.
Teladoc Health Inc. (NYSE: TDOC) was started with an Overweight rating at Stephens. The stock closed up over 4% at $218 on Monday with a $178.87 consensus target price.
Tesla Inc. (NASDAQ: TSLA) was reiterated as Underweight but its price target was raised to $740 from $650 at Morgan Stanley. Tesla closed up over 13% at $1,371.58 ahead of the call, and its shares are now up over 40% in the past week or so.
Uber Technologies Inc. (NYSE: UBER) was reiterated as Outperform and the price target was raised to $42 from $37 (versus a $32.42 close) at JMP Securities.
Unum Therapeutics Inc. (NASDAQ: UMRX) was raised to Outperform from Neutral with a $4 price target (versus a $2.20 close) at Wedbush.
Vaxcyte Inc. (NASDAQ: PCVX) was started as Buy with a $40 price target (versus a $29.38 close) at Needham. The 52-week range is $17.80 to $36.50.
YETI Holdings Inc. (NYSE: YETI) was downgraded to Neutral from Buy but the price target was raised to $40 from $31 at Goldman Sachs.
In addition, BofA Securities is out with its top picks for the third quarter.
Sponsored: Tips for Investing
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.